Screening for Breast Cancer Brain Metastases - Metastatic Breast Cancer Trial Talk

From the Experts

Breast cancer brain metastases (BCBM) screening is when an imaging test, such as an MRI, is used to look for BCBM in a person who is not experiencing symptoms of brain metastases. The current NCCN (National Comprehensive Cancer Network) guidelines do not recommend screening people with advanced breast cancer for BCBM.

However, people have begun to question the NCCN guidelines for BCBM screening. Research shows that because newer treatment options help some people with metastatic breast cancer live longer with the disease, an increasing percentage of people with MBC will eventually develop BCBM. Moreover, newer European research suggests that screening for BCBM may improve the quality of life and survival of some metastatic breast cancer patients with BCBM.

Read the following articles to learn more about screening for breast cancer brain metastases.

Pros & Cons of BCBM Screening
Brain Mets Screening: Comparing Advanced Breast & Lung Cancer Guidelines
Academic Journal Articles about BCBM Screening 
Clinical Trials for BCBM

Last Modified on March 11, 2021



for past articles or specific information.